TCP Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

TCP Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Buy	1,214 +9	+0.7%	+$1.55K	0.03%	127
2026 Q1	$204K	Hold	1,205	–	–	0.03%	125
2025 Q4	$203K	Buy	+1,205	New	+$196K	0.03%	107
2024 Q3	–	Sell	-1,487	Closed	-$204K	–	91
2024 Q2	$204K	Sell	1,487 -57	-4%	-$7.61K	0.05%	71
2024 Q1	$212K	Sell	1,544 -492	-24%	-$67.2K	0.06%	72
2023 Q4	$277K	Sell	2,036 -21,539	-91%	-$2.63M	0.1%	55
2023 Q3	$2.88M	Buy	23,575 +1,182	+5%	+$150K	1.23%	25
2023 Q2	$2.84M	Buy	22,393 +4,391	+24%	+$570K	1.21%	25
2023 Q1	$2.33M	Buy	18,002 +4,436	+33%	+$581K	1.28%	22
2022 Q4	$1.78M	Buy	+13,566	New	+$1.75M	1.39%	20

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

TCP Asset Management's IBB Position: Q2 2026 in Review

TCP Asset Management increased its iShares Biotechnology ETF (IBB) stake by 0.75% in Q2 2026, buying an estimated $1.55K and bringing the position to 1,214 shares worth $231K. The position accounts for 0.03% of the portfolio, ranked #127.

TCP Asset Management first reported a position in IBB in Q4 2022 and has held it in 10 quarters since. The position peaked at $2.88M in Q3 2023. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

TCP Asset Management held 1,214 shares of iShares Biotechnology ETF worth $231K as of Q2 2026.
TCP Asset Management bought 9 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.55K.
iShares Biotechnology ETF made up 0.03% of TCP Asset Management's portfolio in Q2 2026, its #127 holding.
TCP Asset Management first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 10 quarters since.
TCP Asset Management's iShares Biotechnology ETF position peaked at $2.88M in Q3 2023.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on TCP Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.